PathAI

PathAI is a digital pathology and AI company founded in 2016 in Boston by Andy Beck, a Stanford-trained pathologist, and Aditya Khosla. The platform applies deep learning to whole-slide images to support pathologists in diagnostics and biopharma customers in translational research.

PathAI serves more than 50 biopharma customers, academic medical centers, and reference labs. The company operates an in-house pathology lab and offers AISight, an integrated digital pathology platform.

PathAI has raised approximately $255 million from General Catalyst, General Atlantic, and D1 Capital Partners.